KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Thermo Fisher Scientific (TMO) EBIAT: 2009-2025

Historic EBIAT for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $1.6 billion.

  • Thermo Fisher Scientific's EBIAT fell 0.55% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 7.42%. This contributed to the annual value of $6.3 billion for FY2024, which is 6.43% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's EBIAT stood at $1.6 billion, which was up 0.19% from $1.6 billion recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's EBIAT peaked at $2.3 billion during Q2 2021, and registered a low of $1.3 billion during Q2 2023.
  • Its 3-year average for EBIAT is $1.5 billion, with a median of $1.6 billion in 2023.
  • Its EBIAT has fluctuated over the past 5 years, first soared by 196.57% in 2021, then crashed by 41.80% in 2023.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's EBIAT stood at $1.7 billion in 2021, then decreased by 5.12% to $1.6 billion in 2022, then grew by 2.03% to $1.6 billion in 2023, then increased by 13.57% to $1.8 billion in 2024, then declined by 0.55% to $1.6 billion in 2025.
  • Its EBIAT was $1.6 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.5 billion in Q1 2025.